Cumulative corticosteroid-sparing effect of anti-interleukin-5/5Ra in eosinophilic asthma

BACKGROUND: Anti-interleukin (IL)-5/IL-5 receptor α (IL-5Ra) therapy has been shown to reduce maintenance oral corticosteroid (OCS) dose in severe eosinophilic asthma. However, the effect on cumulative OCS exposure is currently unknown. Neither is it known how prior OCS exposure affects response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroes, Johannes A., Zielhuis, Sybrand W.J., De Jong, Kim, Hashimoto, Simone, Sont, Jacob K., Zielhuis, Sander W., Van Roon, Eric N., Bel, Elisabeth H., Ten Brinke, Anneke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630606/
https://www.ncbi.nlm.nih.gov/pubmed/35595317
http://dx.doi.org/10.1183/13993003.02983-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630606/
https://www.ncbi.nlm.nih.gov/pubmed/35595317
http://dx.doi.org/10.1183/13993003.02983-2021

Ejemplares similares